Showing 271-280 of 334 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Determining how NKG2D signaling drives autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-September-2023 to 31-August-2026 | $750,000.00 |
| Engineering a novel Treg population to control autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-April-2025 to 31-March-2026 | $199,999.62 |
| Achieving immune protection in islet transplantation by combining peptide-loaded nanoparticles with conformal coating of islets | University of Kansas Medical Center Research Institute, Inc. | Hubert Tse | Cures | 01-April-2024 to 31-March-2026 | $599,998.25 |
| Enabling studies to advance intra-lymph node depots as a durable antigen-specific immunotherapy for T1D | University of Maryland | Christopher Jewell | Cures | 01-February-2023 to 31-January-2026 | $989,997.00 |
| In vivo interactions and trafficking of islet antigen-specific human effector T cells and Tregs | University of Massachusetts Medical School | Michael Brehm | Cures | 01-November-2024 to 31-October-2027 | $825,000.00 |
| A Cure for Type 1 Diabetes | University of Massachusetts Medical School | David Harlan | Cures | 01-October-2022 to 30-September-2025 | $12,998,645.40 |
| mIL-2/CD25 fusion protein and BTK inhibitor combination therapy for T1D | University of Miami | Wasif Khan | Cures | 01-May-2023 to 30-April-2026 | $974,996.00 |
| Low-dose IL-2 and anti-CD40L as a therapy for type 1 diabetes | University of Miami | Thomas Malek | Cures | 01-June-2024 to 31-May-2027 | $927,000.00 |
| Enhance β-Cell Replacement Therapies via Localized Immune Modulation Using DIANA Nanocarriers | University of Miami | Peter Buchwald | Cures | 01-September-2023 to 31-August-2026 | $900,000.00 |
| Modulate beta cell proliferation and immunogenicity via aptamer-decorated lipid nanoparticles | University of Miami | Paolo Serafini | Cures | 01-April-2023 to 31-March-2026 | $894,602.00 |